 | • レポートコード：STR-DC012 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療IT |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、臨床試験管理システムの世界市場について調査・分析し、調査手法、市場概要、種類別（エンタープライズ、サイト）分析、コンポーネント別（ソフトウェア、サービス）分析、デリバリーモード別（オンプレミス、ウェブベース、クラウドベース）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・臨床試験管理システムの世界市場：種類別（エンタープライズ、サイト） ・臨床試験管理システムの世界市場：コンポーネント別（ソフトウェア、サービス） ・臨床試験管理システムの世界市場：デリバリーモード別（オンプレミス、ウェブベース、クラウドベース） ・臨床試験管理システムの世界市場：地域別 ・企業概要 |
A CTMS (Clinical Trial Management System) is a customized software system is designed by organizations such as medical device and biotechnology companies. Clinical trial management systems (CTMS) have been intended as stand-alone applications for either research sites or for the organizations that multi-site research, including SMOs, CROs, AMCs provider networks, and several others. Currently, it has become apparent in the research industry to collaborate between these two types of systems to improve communication between organizations. Thus, CTMS bridges the communication gap and provides an effective solution for both companies.
The global clinical trial management system (CTMS) market is expected to reach USD 1,577 million by 2025 at a CAGR of 14.1% during the forecast period 2018–2025.
Market Dynamics
Increasing prevalence of chronic diseases, continuously growing clinical research, and rising trend of outsourcing clinical trials are expected to drive the market. Moreover, increased public and private funding as well as favorable government policies are additional factors influencing market growth. Economic development and improvement in regulatory and patent expiration laws in regions such as Japan, China, and India have led to the expansion of the CTMS. Furthermore, low cost of conducting clinical trials in these regions is expected to propel the market growth.
The global clinical trial management system market is expected to grow at a CAGR of 14.1% during the forecasted period, 2018–2025. By delivery mode, the web-based CTMS accounted for USD 86.1 million in 2017.
Segmentation
By type, the global clinical trial management system market is segmented into enterprise CTMS and site CTMS.
Based on the component, the market is bifurcated into software and services.
On the basis of delivery mode, the market is categorized into cloud, web-based, and on-premises
Based on the end user, the market is categorized into contract research organization, medical device companies, pharmaceutical & biopharmaceutical companies, and others.
Regional Analysis
Geographically, the global clinical trial management system market is segmented into North America, Europe, Asia Pacific, and the Latin America and the Middle East & Africa (LAMEA).
North America accounts for the largest share of the clinical trial management system market owing to deployment of advanced contract research organization technologies. Moreover, the presence of well-established contract research organization infrastructure and greater awareness regarding preventive contract research organization measures boost the growth of this region. Furthermore, a large number of on-going clinical trials, increasing government support, and a large customer base are expected to boost the market growth in the coming years . For instance, according to food & drug administration (FDA) in 2016, the U.S. was the major contributor to the development of clinical trials. The trial participants from the U.S accounted for more than 30% share globally.
Europe was the second largest market for in clinical trial management system in 2017 and is expected keep its market position intact in the coming years. Countries in Central and Eastern Europe provide abundant opportunities to life science companies in clinical development.
Asia Pacific is a fastest growing region in global clinical trial management system market owing to rapidly growing healthcare expenditure in this region. Moreover, increasing need for traditional and innovative therapies and medical devices for treatments also contributes to the growth of this market. Clinical trials in the Asia Pacific except Japan are considerably cheaper than in the western countries. One of the main factors contributing to lower costs of outsourcing clinical trials in Asia is patient recruitment for clinical trials is easier and faster.
Key Players
Some of the key players in the global market are ArisGlobal, LLC (U.S.), BioClinica, Inc. (U.S.), Bio-Optronics, Inc. (U.S.), DSG Inc (U.S.), IBM Watson Health (U.S.), Medidata Solutions (U.S.), Nextrials, Inc. (U.S.), Oracle Corp. (U.S.), PAREXEL International Corp. (U.S.), and Veeva Systems, Inc. (U.S.)
A CTMS (Clinical Trial Management System) is a customized software system is designed by organizations such as medical device and biotechnology companies. Clinical trial management systems (CTMS) have been intended as stand-alone applications for either research sites or for the organizations that multi-site research, including SMOs, CROs, AMCs provider networks, and several others. Currently, it has become apparent in the research industry to collaborate between these two types of systems to improve communication between organizations. Thus, CTMS bridges the communication gap and provides an effective solution for both companies.
The global clinical trial management system (CTMS) market is expected to reach USD 1,577 million by 2025 at a CAGR of 14.1% during the forecast period 2018–2025.
Market Dynamics
Increasing prevalence of chronic diseases, continuously growing clinical research, and rising trend of outsourcing clinical trials are expected to drive the market. Moreover, increased public and private funding as well as favorable government policies are additional factors influencing market growth. Economic development and improvement in regulatory and patent expiration laws in regions such as Japan, China, and India have led to the expansion of the CTMS. Furthermore, low cost of conducting clinical trials in these regions is expected to propel the market growth.
The global clinical trial management system market is expected to grow at a CAGR of 14.1% during the forecasted period, 2018–2025. By delivery mode, the web-based CTMS accounted for USD 86.1 million in 2017.
Segmentation
By type, the global clinical trial management system market is segmented into enterprise CTMS and site CTMS.
Based on the component, the market is bifurcated into software and services.
On the basis of delivery mode, the market is categorized into cloud, web-based, and on-premises
Based on the end user, the market is categorized into contract research organization, medical device companies, pharmaceutical & biopharmaceutical companies, and others.
Regional Analysis
Geographically, the global clinical trial management system market is segmented into North America, Europe, Asia Pacific, and the Latin America and the Middle East & Africa (LAMEA).
North America accounts for the largest share of the clinical trial management system market owing to deployment of advanced contract research organization technologies. Moreover, the presence of well-established contract research organization infrastructure and greater awareness regarding preventive contract research organization measures boost the growth of this region. Furthermore, a large number of on-going clinical trials, increasing government support, and a large customer base are expected to boost the market growth in the coming years . For instance, according to food & drug administration (FDA) in 2016, the U.S. was the major contributor to the development of clinical trials. The trial participants from the U.S accounted for more than 30% share globally.
Europe was the second largest market for in clinical trial management system in 2017 and is expected keep its market position intact in the coming years. Countries in Central and Eastern Europe provide abundant opportunities to life science companies in clinical development.
Asia Pacific is a fastest growing region in global clinical trial management system market owing to rapidly growing healthcare expenditure in this region. Moreover, increasing need for traditional and innovative therapies and medical devices for treatments also contributes to the growth of this market. Clinical trials in the Asia Pacific except Japan are considerably cheaper than in the western countries. One of the main factors contributing to lower costs of outsourcing clinical trials in Asia is patient recruitment for clinical trials is easier and faster.
Key Players
Some of the key players in the global market are ArisGlobal, LLC (U.S.), BioClinica, Inc. (U.S.), Bio-Optronics, Inc. (U.S.), DSG Inc (U.S.), IBM Watson Health (U.S.), Medidata Solutions (U.S.), Nextrials, Inc. (U.S.), Oracle Corp. (U.S.), PAREXEL International Corp. (U.S.), and Veeva Systems, Inc. (U.S.)
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Clinical Trial Management System Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Pricing Analysis
3.7 Market Trends
4 By Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Enterprise
4.3 Site
5 By Component Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Software
5.3 Services
6 Delivery Mode
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 On Premise
6.3 Web Based
6.4 Cloud Based
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Type
7.2.1.1.2 By Component
7.2.1.1.3 By Delivery Mode
7.2.1.2 Canada
7.2.1.2.1 By Type
7.2.1.2.2 By Component
7.2.1.2.3 By Delivery Mode
7.2.1.3 Mexico
7.2.1.3.1 By Type
7.2.1.3.2 By Component
7.2.1.3.3 By Delivery Mode
7.2.4 Latin America
7.2.4.1 By Type
7.2.4.2 By Component
7.2.4.3 By Delivery Mode
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Germany
7.3.2.1 By Type
7.2.2.2 By Component
7.3.2.3 By Delivery Mode
7.3.3 France
7.3.3.1 By Type
7.3.3.2 By Component
7.3.3.3 By Delivery Mode
7.3.4 U.K.
7.3.4.1 By Type
7.3.4.2 By Component
7.3.4.3 By Delivery Mode
7.3.5 Italy
7.3.5.1 By Type
7.3.5.2 By Component
7.3.5.3 By Delivery Mode
7.3.6 Spain
7.3.6.1 By Type
7.3.6.2 By Component
7.3.6.3 By Delivery Mode
7.3.7 Rest of Europe
7.3.7.1 By Type
7.3.7.2 By Component
7.3.7.3 By Delivery Mode
7.4 Asia-Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 Japan
7.4.2.1 By Type
7.4.2.2 By Component
7.4.2.3 By Delivery Mode
7.4.3 China
7.4.3.1 By Type
7.4.3.2 By Component
7.4.3.3 By Delivery Mode
7.4.4 Australia
7.4.4.1 By Type
7.4.4.2 By Component
7.4.4.3 By Delivery Mode
7.4.5 India
7.4.5.1 By Type
7.4.5.2 By Component
7.4.5.3 By Delivery Mode
7.4.6 South Korea
7.4.6.1 By Type
7.4.6.2 By Component
7.4.6.3 By Delivery Mode
7.4.7 Rest of Asia-Pacific
7.4.7.1 By Type
7.4.7.2 By Component
7.4.7.3 By Delivery Mode
7.5 Middle East & Africa
7.5.1 Market Size & Forecast (Value)
7.5.2 Saudi Arabia
7.5.2.1 By Type
7.5.2.2 By Component
7.5.2.3 By Delivery Mode
7.5.3 South Africa
7.5.3.1 By Type
7.3.3.2 By Component
7.5.3.3 By Delivery Mode
7.5.4 Rest of Middle East & Africa
7.5.4.1 By Type
7.5.4.2 By Component
7.5.4.3 By Delivery Mode
8. Company Profile
8.1 ArisGlobal, LLC
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 BioClinica, Inc.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Bio-Optronics, Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 DSG Inc
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 IBM Watson Health
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 Medidata Solutions
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 Nextrials, Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 Oracle Corp
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
8.9 PAREXEL International Corp
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Recent Developments
8.9.4 Product Portfolio
8.10 Veeva Systems, Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Recent Developments
8.10.4 Product Portfolio
TABLE 1 Global Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 2 Clinical Trial Management System Market Share for Enterprise, By Region, 2016 – 2026 ($ Million)
TABLE 3 Clinical Trial Management System Market Share for Site, By Region, 2016 – 2026, ($ Million)
TABLE 4 Global Clinical Trial Management System Market Share, By Component, 2016 – 2026 ($Million)
TABLE 5 Software Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 6 Services Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 7 Global Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 8 On Premise Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 9 Web Based Channel Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 10 Cloud Based Channel Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 11 Global Clinical Trial Management System Market Share Value, 2016 – 2026 ($Million)
TABLE 12 North America Clinical Trial Management System Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 13 North America Clinical Trial Management System Market Share Value, By Type, 2016 – 2026 ($Million)
TABLE 14 North America Clinical Trial Management System Market Share Value, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 15 U.S. Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 16 U.S. Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 17 Canada Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 18 Canada Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 19 Mexico Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 20 Mexico Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 21 South America Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 22 South America Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 23 Europe Clinical Trial Management System Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 24 Europe Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 25 Europe Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 26 Germany Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 27 Germany Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 28 France Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 29 France Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 30 UK Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 31 UK Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 32 Italy Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 33 Italy Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 34 Spain Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 35 Spain Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 36 Rest of Europe Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 37 Rest of Europe Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 38 Asia-Pacific Clinical Trial Management System Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 39 Asia-Pacific Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 40 Asia-Pacific Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 41 Japan Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 42 Japan Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 43 China Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 44 China Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 45 Australia Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 46 Australia Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 47 India Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 48 India Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 49 South Korea Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 50 South Korea Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 51 Rest of Asia-Pacific Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 52 Rest of Asia-Pacific Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 53 MEA Clinical Trial Management System Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 54 MEA Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 55 MEA Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 56 Saudi Arabia Clinical Trial Management System Market Share, By Type, 2016-2025 ($Million)
TABLE 57 Saudi Arabia Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 58 South Africa Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 59 South Africa Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 60 UAE Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 61 UAE Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
TABLE 62 Rest of MEA Clinical Trial Management System Market Share, By Type, 2016 – 2026 ($Million)
TABLE 63 Rest of MEA Clinical Trial Management System Market Share, By Delivery Mode, 2016 – 2026 ($Million)
List of Figures
FIGURE 1 Global Clinical Trial Management System Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Global Clinical Trial Management System Market Share Analysis, 2018
FIGURE 9 Global Clinical Trial Management System Market, 2016-2026
FIGURE 10 Americas Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 11 North America Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 12 U.S. Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 13 Canada Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 14 Mexico Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 15 South America Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 16 Europe Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 17 Germany Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 18 France Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 19 UK Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 20 Italy Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 21 Spain Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 22 Rest of Europe Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 23 Asia Pacific Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 24 Japan Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 25 China Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 26 Australia Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 27 India Global Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 28 South Korea Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 29 Rest of Asia-pacific Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 30 MEA Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 31 Kuwait Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 32 Saudi Arabia Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 33 South Africa Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 34 Rest of MEA Clinical Trial Management System Market Share, 2016-2026 ($Million)
FIGURE 35 IBM: Revenue Analysis, ($ million)
FIGURE 36 IBM: Segment Revenue 2017 (%)